Compare CRVS & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRVS | BHRB |
|---|---|---|
| Founded | 2014 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 968.8M |
| IPO Year | 2016 | 2023 |
| Metric | CRVS | BHRB |
|---|---|---|
| Price | $12.68 | $66.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $30.17 | ★ $71.80 |
| AVG Volume (30 Days) | ★ 1.3M | 175.2K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | 48.04 | ★ 173.76 |
| EPS | N/A | ★ 1.79 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $36.62 |
| Revenue Next Year | N/A | $10.06 |
| P/E Ratio | ★ N/A | $36.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.71 | $56.35 |
| 52 Week High | $26.95 | $70.90 |
| Indicator | CRVS | BHRB |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 61.54 |
| Support Level | $11.13 | $61.25 |
| Resistance Level | $14.00 | $67.53 |
| Average True Range (ATR) | 0.66 | 1.50 |
| MACD | 0.24 | 0.12 |
| Stochastic Oscillator | 83.26 | 86.58 |
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.